Deutsche Bank Ag\ Argenx Se Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Argenx Se stock. As of the latest transaction made, Deutsche Bank Ag\ holds 106,690 shares of ARGX stock, worth $60.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

106,690

Previous 159,607 33.15%

Holding current value

$60.2 Million

Previous $68.6 Million 15.7%

% of portfolio

0.02%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$434.22 - $551.9 $23 Million - $29.2 Million	-52,917 Reduced 33.15%	106,690 $57.9 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $14,240 - $18,062	40 Added 0.03%	159,607 $68.6 Million
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $10.7 Million - $12.3 Million	-29,838 Reduced 15.75%	159,567 $62.8 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $61.8 Million - $92.3 Million	182,427 Added 2614.32%	189,405 $72.1 Million
Q3 2023 Nov 09, 2023	SELL	$369.35 - $548.43 $54.4 Million - $80.7 Million	-147,197 Reduced 95.47%	6,978 $3.43 Million
Q2 2023 Aug 14, 2023	SELL	$360.14 - $422.58 $99.8 Million - $117 Million	-277,059 Reduced 64.25%	154,175 $60.1 Million
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $8,355 - $10,091	-25 Reduced 0.01%	431,234 $161 Million
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $3.59 Million - $4.22 Million	10,500 Added 2.5%	431,259 $163 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $25.3 Million - $29.2 Million	73,792 Added 21.27%	420,759 $149 Million
Q2 2022 Aug 11, 2022	BUY	$269.58 - $378.88 $10.6 Million - $14.9 Million	39,427 Added 12.82%	346,967 $131 Million
Q1 2022 May 13, 2022	BUY	$254.45 - $351.06 $77 Million - $106 Million	302,725 Added 6287.12%	307,540 $97 Million
Q4 2021 Feb 11, 2022	SELL	$272.01 - $353.03 $934,354 - $1.21 Million	-3,435 Reduced 41.64%	4,815 $1.69 Million
Q3 2021 Nov 04, 2021	BUY	$295.0 - $350.58 $1.39 Million - $1.65 Million	4,712 Added 133.18%	8,250 $2.49 Million
Q2 2021 Aug 11, 2021	SELL	$257.11 - $319.92 $2.27 Million - $2.83 Million	-8,837 Reduced 71.41%	3,538 $1.07 Million
Q1 2021 May 13, 2021	BUY	$268.3 - $380.31 $1.19 Million - $1.69 Million	4,437 Added 55.9%	12,375 $3.41 Million
Q4 2020 Feb 16, 2021	BUY	$248.13 - $308.36 $586,083 - $728,346	2,362 Added 42.36%	7,938 $2.34 Million
Q3 2020 Nov 12, 2020	SELL	$215.51 - $272.51 $3.99 Million - $5.05 Million	-18,516 Reduced 76.86%	5,576 $1.46 Million
Q2 2020 Aug 13, 2020	BUY	$127.44 - $232.72 $3.05 Million - $5.58 Million	23,967 Added 19173.6%	24,092 $5.43 Million
Q1 2020 May 14, 2020	SELL	$108.83 - $165.23 $4.54 Million - $6.9 Million	-41,761 Reduced 99.7%	125 $16,000
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $2.5 Million - $3.85 Million	23,439 Added 127.06%	41,886 $6.72 Million
Q3 2019 Nov 14, 2019	SELL	$113.31 - $150.51 $6.47 Million - $8.59 Million	-57,088 Reduced 75.58%	18,447 $2.1 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $2.51 Million - $3.09 Million	21,795 Added 40.56%	75,535 $10.7 Million
Q1 2019 May 15, 2019	BUY	$98.85 - $134.59 $4.71 Million - $6.41 Million	47,616 Added 777.53%	53,740 $6.71 Million
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $705,100 - $1.21 Million	-11,050 Reduced 64.34%	6,124 $588,000
Q3 2018 Dec 21, 2021	BUY	$75.5 - $96.63 $401,886 - $514,361	5,323 Added 44.92%	17,174 $1.3 Million
Q3 2018 Nov 14, 2018	SELL	$75.5 - $96.63 $1.68 Million - $2.15 Million	-22,202 Reduced 65.2%	11,851 $898,000
Q2 2018 Aug 14, 2018	SELL	$74.84 - $100.16 $4.25 Million - $5.68 Million	-56,759 Reduced 62.5%	34,053 $2.82 Million
Q1 2018 May 15, 2018	SELL	$56.95 - $85.19 $78,591 - $117,562	-1,380 Reduced 1.5%	90,812 $7.3 Million
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $2.01 Million - $5.67 Million	89,184 Added 2964.89%	92,192 $5.82 Million
Q3 2017 Nov 14, 2017	BUY	$19.81 - $22.61 $59,588 - $68,010	3,008	3,008 $68,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account